pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Preclinical
OQY-8811
Multiple Myeloma (Kahler Disease)
Oqory Inc
Preclinical
OR-449
Adrenocortical Carcinoma (Adrenal Cortex Cancer)
Orphagen Pharmaceuticals Inc
Preclinical
OR-812
Male Contraception
Orphagen Pharmaceuticals Inc
Preclinical
← prev
page 118 of 231
next →
Pain
89
Neurology
1
ORG-101
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphobla…
Orgenesis Inc
Phase 2
ORKA-001
Plaque Psoriasis (Psoriasis Vulgaris)
$ORKA
Oruka Therapeutics, Inc.
Phase 2
ORTHO-R
Unspecified Musculoskeletal Disorders
ChitogenX Inc
Phase 2
ORX-142
Sleep Disorders
$CNTA
Centessa Pharmaceuticals plc
Preclinical
OS-151
Tuberculosis
OncoSTING LLC
Phase 3
OSE-2101
Tedopi
Non-Small Cell Lung Cancer
OSE Immunotherapeutics SA
Preclinical
OT-004
Leber Congenital Amaurosis (LCA)
Odylia Therapeutics Inc
Phase 2
OTL-201
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome )
Kyowa Kirin Co Ltd
Phase 1
OTOV-101
Deafness
Suzhou Otovia Therapeutics Co Ltd
Phase 1
OTS-167
Metastatic Breast Cancer
OncoTherapy Science Inc
Phase 1
OV-329
Seizures
$OVID
Ovid Therapeutics Inc.
Preclinical
OX-390
Acute Opioid Overdosage
Orexo AB
Phase 2
OXI-4503
Refractory Acute Myeloid Leukemia
$OTLC
Oncotelic Therapeutics, Inc.
OXYGEN
OXYGEN
no indication
AIR LIQUID INDUSTRIAL US LP
OZILTUS
OZILTUS (DENOSUMAB-MOBZ)
no indication
AMNEAL PHARMS LLC
Preclinical
Obesity
Obesity
Metallomix Inc
Preclinical
Oligonucleotide for Charcot-Marie-Tooth Disease Type I A
Charcot-Marie-Tooth Disease Type I A
MaasiRNA
Phase 3
OncoVAX
OncoVAX
Colon Cancer
Vaccinogen Inc
Preclinical
Oncolipin-IT
Colorectal Cancer
XEME BioPharma Inc
Preclinical
Oncoplex
Glioblastoma Multiforme (GBM)
$PYPD
PolyPid Ltd.
Phase 1
Oncoquest
Oncoquest
Chronic Lymphocytic Leukemia (CLL)
XEME BioPharma Inc
Marketed
Oncotice
Tice BCG
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial B…
$MRK
Merck & Co., Inc.
Phase 2
OpRegen
OpRegen
Geographic Atrophy
F. Hoffmann-La Roche Ltd
Phase 2
Optiquel
Optiquel
Non-infectious Uveitis
Enzo Biochem Inc
Marketed
Opzelura
Opzelura (ruxolitinib phosphate)
Hidradenitis Suppurativa
$INCY
INCYTE CORP
Marketed
Orabloc
Orabloc ((articaine hydrochloride + epinephrine bitartrate))
Local Anesthetic Effect
Pierrel SpA
Phase 2
Organ Dysfunction/Mortality
Unspecified
BioAegis Therapeutics Inc
